Article
Mutational and immunologic Landscape in malignant Salivary Gland Tumors harbor the potential for novel therapeutic strategies.
Critical reviews in oncology/hematology - 1 Feb 2022
Witte Hanno M, Gebauer Niklas, Steinestel Konrad
Abstract excerpt
Salivary gland carcinomas (SGC) are rare (3-6 % of all head and neck cancers) and show biological heterogeneity depending on the respective histological subtype. While complete surgical resection is the standard treatment for localized disease, chemotherapy or radiation therapy are frequently insufficient for the treatment of unresectable or metastasized SGC. Therefore, new therapeutic approaches such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
